Related Experiment Video
Updated: Jul 7, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Analysis of the Larissa Heart Failure Risk Score: Predictive Value in 9207 Patients Hospitalized for Heart Failure
Andrew Xanthopoulos1, John Skoularigis1, Alexandros Briasoulis2
1Department of Cardiology, University General Hospital of Larissa, 41110 Larissa, Greece.
The Larissa Heart Failure Risk Score (LHFRS) effectively predicts one-year outcomes for hospitalized heart failure (HHF) patients. This simple score aids in early risk stratification for better patient management.
Area of Science:
- Cardiology
- Clinical Medicine
- Health Services Research
Background:
- Early risk stratification is crucial for managing hospitalized heart failure (HHF) patients.
- Existing risk models may lack simplicity or broad applicability for HHF.
- The Larissa Heart Failure Risk Score (LHFRS) offers a potentially straightforward approach.
Purpose of the Study:
- To evaluate the predictive accuracy of the Larissa Heart Failure Risk Score (LHFRS) in a large HHF cohort.
- To assess the LHFRS's ability to predict one-year heart failure readmission and all-cause mortality.
Main Methods:
- Retrospective analysis of 13,309 HHF admissions from 9207 unique patients at Cleveland Clinic.
- Utilized the 3-variable LHFRS: hypertension history, myocardial infarction history, and red blood cell distribution width (RDW) ≥ 15%.
- Assessed primary (HF readmission/all-cause mortality) and secondary (all-cause mortality) outcomes at one year.
Main Results:
- All LHFRS components were statistically significant predictors for both outcomes (Log-rank test p < 0.001).
- Higher LHFRS scores demonstrated a strong association with adverse one-year events.
- Logistic regression models showed a C-index of 0.64 for both primary and secondary outcomes.
Conclusions:
- The LHFRS is a simple, validated tool for risk stratification in patients hospitalized for heart failure.
- Its components effectively predict one-year adverse outcomes, including readmission and mortality.
- The LHFRS can serve as a foundation for clinical decision-making and patient management strategies.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Hazard Ratio
For example, in a clinical trial...
Heart Failure Drugs: Diuretics
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

